Patients with Guillain-Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Annexon, Inc. presented promising findings regarding its investigational therapy tanruprubart at the 2025 Peripheral Nerve Society Annual Meeting. The oral presentation highlighted the benefits of ...

Please provide your email address to receive an email when new articles are posted on . A validated tool was able to predict the inability to walk unaided at 4 and 26 weeks among patients with ...

KYOTO, Japan — Eculizumab (Soliris, Alexion Pharmaceuticals) is safe for the treatment of patients with severe Guillain-Barré syndrome (GBS), a new phase 2 study shows. However, although more patients ...

A MAN who was paralysed by a rare autoimmune disorder stunned doctors by learning to walk again after a world-first plasma ...

DEAR DR. ROACH: I am a 73-year-old female with atrial fibrillation (AFib) who recently had a pacemaker implant and has been doing well since. I also have a thyroid gland disorder, and I’m taking daily ...

A 85-year-old patient has recovered successfully at Zulekha Hospital, Dubai after being treated for Guillain–Barré Syndrome (GBS), which is a condition in which the body's immune system attacks the ...

Guillain-?Barr Syndrome is a rare condition in which a person's immune system attacks the peripheral nerves. People affected suffer from muscle weakness and paralysis. A research team led by ETH ...

CONSHOHOCKEN, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- May is GBS|CIDP Awareness Month and this year marks 110 years since the discovery of Guillain-Barré syndrome (GBS), which was first identified and ...